This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceuticalmanufacturing, the addition of AI technologies introduce a paradigm shift. Integrative Analysis of Multi-Omics Data with Deep Learning: Challenges and Opportunities in Bioinformatics.
This poses a significant challenge for pharmaceuticalmanufacturers, not least because of the technical challenges related to operations, supply chain and the environment. This article explores the potential impact of the proposal and considers how manufacturers can ensure the safety and reliability of their products.
According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), more than 600 essential medicines are at risk if a proposed restriction on the use of fluorinated substances, per- and polyfluoroalkyl substances (PFAS) across pharmaceuticalmanufacturing in the EEA, is implemented.
Examples include infrared (IR) spectrometers or pH meters that can be used to further enhance the capabilities of the predictive model, leading to improved outcomes when it comes to product quality and efficiency. In April 2022 both companies were acquired by Bruker.
He leads the Program on Regulation, Therapeutics, and Law at Brigham and Women’s Hospital in Boston. Meanwhile, the top 25 pharmaceutical companies reported a “healthy average operating margin of 22 percent” at the end of 2017, according to an analysis by GlobalData.
Discover the leading patient adherence pharmaceutical companies. Pharmaceutical Technology has listed the top patient adherence pharmaceutical companies based on our intel, insights and decades-long expertise in the sector.
Pharmaceutical wholesalers act as intermediaries between pharmaceuticalmanufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Discover the top pharmaceutical wholesalers. GDP and GMP advisory. Temperature control facilities and supply solutions.
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. This news follows the company beginning construction on a similar facility in France , which is set to produce lead-212 radioligand therapies for the European market.
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
The Association of the British Pharmaceutical Industry (ABPI) has drawn attention to a new report , which has emphasised the importance of UK advanced manufacturing requiring a long-term strategy to ensure its continued success. Article: Are we globally prepared for the next pandemic?
Pharmaceutical Technology has listed the leading API chemical companies in contract marketing based on its intel, insights, and decades of experience in the sector. The post Leading API chemical companies in contract marketing appeared first on Pharmaceutical Technology.
Importantly, spectroscopy techniques utilising molecular spectroscopy enable manufacturers to gain “real-time input on process parameters, which helps firms improve production processes, enhance productivity, and reduce costs”. This enables pharmaceutical companies to monitor their manufacturing processes at various stages.
Commercial dose companies form a critical component of the pharmaceuticalmanufacturing industry’s value chain. The dose form manufacturing follows API manufacturing to produce the final dosage form (FDF such as tablets and injectables. Discover the leading commercial dose companies in contract marketing.
SMS Pharmaceuticals Ltd- Walk-Ins for Production/ Quality Control/ IT Dept. SMS Pharmaceuticals Ltd is one of the leadingpharmaceuticalmanufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards. On 24th Sept’ 2022.
Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. The post Leading commercial dose (non-sterile) companies in contract marketing appeared first on Pharmaceutical Technology.
Pharmaceutical Technology has listed some of the leading contract commercial packaging companies, based on its intel, insights and decades-long experience in the sector. The post Leading commercial packaging companies in contract marketing appeared first on Pharmaceutical Technology.
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
However, with cleanrooms-on-demand representing a feasible and accessible opportunity for those across pharmaceuticalmanufacturing, what are the key challenges in adoption and how can we expect the industry to overcome them to reap the rewards on offer? But with a single dedicated cleanroom environment costing around $2.5
Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceuticalmanufacturing and innovation. Reducing the facilities carbon impact will also be supported by the expansion. AbbVie announces Michael Severino, M.D.
Breast cancer treatment is an intricate field, with ongoing research and development leading to new and innovative therapies. Lab data, coupled with strategic HCP engagement, plays a crucial role in helping pharmaceuticalmanufacturers navigate this complex landscape.
UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing processes across the UK.” Curious about sustainability in pharmaceuticalmanufacturing and the supply chain?
Consequently, pharmaceuticalmanufacturers risk their reputation if impersonating products fail to deliver the expected quality or health impact. Lean pharmaceuticalmanufacturing may mean bringing the entire supply chain under one roof to facilitate speed, cost savings and, most importantly, a safe and secure offering for patients.
In recent years, nitrosamines have been detected in various medicines, leading to voluntary product recalls from the market. Nitrosamines analysis is, thus, key to ensuring safety and quality in the pharmaceutical industry.
The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceuticalmanufacturing site quality rating system, the Quality management maturity (QMM) programme.
Among the 25 worldwide companies that spend the most on research and development—all more than $5 billion a year—seven are pharmaceuticalmanufacturers, but eight are automobile or automobile-parts companies with profit margins under 10 percent. Amazon’s operating margin is under 5 percent.
There is an opportunity for the UK to lead global development, new technologies, and metrics of medicines manufacturing sustainability goals, according to the MMIP, which is pushing for changes to the R&D tax relief framework to create the right fiscal environment for growth. .
With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Buy the report here. The overall index for environmental sustainability in Q1 2023 was 107.
The most prominent among them include: AI misinterpretation of critical information: As an example, a team might ask ChatGPT to answer a question, and the AI engine may deliver an impressive volume of information, while misaligning with the core business, leading to conclusions that are either overvalued or flat-out wrong.
Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.
Todd Somsel , Commercial Lead, RWD Marketplace The acceptance and application of real-world evidence (RWE) by stakeholders across the healthcare industry continues its rapid pace of growth.
Globally, the pharmaceutical sector emitted around 52 megatonnes of CO 2 in 2015, the most recent period for which detailed numbers are available. 1 Every major pharmaceuticalmanufacturer in the UK and Ireland is investing in making their operations and supply chains more environmentally friendly.
With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate corporate governance. Of the 50 leading companies in the pharmaceutical industry, GSK had the greatest increase in references for corporate governance in Q1 2023, compared with the previous quarter. Buy the report here.
When questioned about which technologies he considered have potential to advance the sector, Chornet emphasised that not only is mRNA as a vaccine technology “a very promising and interesting platform [but that it is] disruptive and a game changer technology for vaccine [manufacturing] and overall biotech.”
SMS Pharmaceuticals Ltd- Walk-Ins for Accounts / Costing/ Finance On 8th Jan’ 2023. SMS Pharmaceuticals Ltd is one of the leadingpharmaceuticalmanufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards.
The CDSCO headquarters conduct regulatory supervision over drug importation, approval of new pharmaceuticals and clinical trials, meetings of the Drugs Consultative Committee (DCC) and Drugs Technical Advisory Board (DTAB), and approval of some licences as the Central Licence Approving Authority.
With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate corporate governance. Of the 50 leading companies in the pharmaceutical industry, GSK had the greatest increase in references for corporate governance in Q1 2023, compared with the previous quarter. Buy the report here.
With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Buy the report here. The overall index for environmental sustainability in Q1 2023 was 107.
With an increasing focus on ESG, Pharmaceutical companies are under pressure to incorporate sustainability with suppliers playing a crucial role in the process. Notably, the number of environmental sustainability-related patent applications in the pharmaceutical industry was 1,948 in Q1 2023, versus 2,528 in the prior quarter.
Bob is a life sciences and technology marketing leader with more than 25 years of experience working directly for pharmaceuticalmanufacturers (Merck, AstraZeneca, and Shire) and for technology companies that serve the industry (Appature, IQVIA, and Sparta). Bob is currently Sr.
When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy. Call to Action Pharmaceuticalmanufacturers continue to push forward with active combination therapy pipelines, seeking to offer improvements over SoC in oncology. Certain markets (e.g.,
What are the three main challenges of monitoring pharmaceuticals in the environment? Andreas Häner (AH): Roche, along with other pharmaceutical companies, acknowledges concerns about pharmaceuticals in the environment (PiE).
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content